Main
Cancers develop through a process of Darwinian evolution within tissues 1 , 4 , 5 , 6 . Mutation, drift and selection in the large cell populations making up our tissues can result in the emergence of a clone that has acquired multiple genetic and epigenetic ‘driver’ alterations that disrupt tissue homeostasis and promote uncontrolled proliferation 7 , 8 , 9 , 10 . Although large-scale sequencing efforts over the last 20 years have provided comprehensive catalogues of the driver genes responsible for cancer development 11 , 12 , 13 , a complete quantitative understanding of the evolutionary dynamics governing how these drivers arise, expand and compete is lacking. Why are cancer driver mutations widespread across many healthy human tissues 2 , 14 , 15 , 16 , 17 , yet cancers of many of these tissues are comparatively rare? Why in some people do initial clonal expansions progress to lethal cancers whereas in others they remain benign?…